Paper39178229
Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors.
Dahal A and 12 others. Proc Natl Acad Sci U S A, 2024. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. Papers, record 39178229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39178229
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neutrophils | Major topic |
| Cell Differentiation | Major topic |
| Tumor Microenvironment | Major topic |
| Platelet Activating Factor | Major topic |
| Myeloid-Derived Suppressor Cells | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Cell Line, Tumor | |
| CD8-Positive T-Lymphocytes | |
| Mice, Inbred C57BL |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Al147362 | HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | PubMed | PubMed | ||
| Al102851 | HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | PubMed | PubMed | ||
| GM007356 | HHS | NIH | National Institute of General Medical Sciences (NIGMS) | T32GM007356 | PubMed and NIH | NIH RePORTER | |
| HL160723 | HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) | R01HL160723 | PubMed and NIH | NIH RePORTER | |
| R01 HL160723 | NHLBI NIH HHS | United States | R01HL160723 | PubMed and NIH | NIH RePORTER |
| T32 GM007356 | NIGMS NIH HHS | United States | T32GM007356 | PubMed and NIH | NIH RePORTER |
| P01AI102851 | NIH | NIH RePORTER | |||
| R01AI147362 | NIH | NIH RePORTER |
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30191175 | PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo. | Sci Adv | 2018 | https://conductscience.org/library/papers/30191175 | PubMed |
| 2 | 35675777 | PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment. | Cell Rep | 2022 | https://conductscience.org/library/papers/35675777 | PubMed |
| 3 | 35190529 | Blocking iASPP/Nrf2/M-CSF axis improves anti-cancer effect of chemotherapy-induced senescence by attenuating M2 polarization. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35190529 | PubMed |
| 4 | 7807024 | Inhibition of tumor growth by elimination of granulocytes. | J Exp Med | 1995 | https://conductscience.org/library/papers/7807024 | PubMed |
| 5 | 14115699 | A STUDY OF THE LEUKEMOID RESPONSE TO TRANSPLANTABLE A-280 TUMOR IN MICE. | Cancer Res | 1964 | https://conductscience.org/library/papers/14115699 | PubMed |
| 6 | 33077737 | Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/33077737 | PubMed |
| 7 | 29348500 | Myeloid-derived suppressor cells coming of age. | Nat Immunol | 2018 | https://conductscience.org/library/papers/29348500 | PubMed |
| 8 | 15313928 | Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. | Cancer Res | 2004 | https://conductscience.org/library/papers/15313928 | PubMed |
| 9 | 34520398 | Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34520398 | PubMed |
| 10 | 21541282 | A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue. | PLoS One | 2011 | https://conductscience.org/library/papers/21541282 | PubMed |
| 11 | 22542595 | The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. | Carcinogenesis | 2012 | https://conductscience.org/library/papers/22542595 | PubMed |
| 12 | 27265504 | CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27265504 | PubMed |
| 13 | 120307 | [Origin and biological role of lipid mediators during inflammation (author's transl)]. | Immun Infekt | 1979 | https://conductscience.org/library/papers/120307 | PubMed |
| 14 | 39178229 | Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39178229 | PubMed |
| 15 | 29445756 | Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor. | J Immunol Res | 2017 | https://conductscience.org/library/papers/29445756 | PubMed |
| 16 | 34439836 | Neutrophil in the Pancreatic Tumor Microenvironment. | Biomolecules | 2021 | https://conductscience.org/library/papers/34439836 | PubMed |
| 17 | 38207030 | Deterministic reprogramming of neutrophils within tumors. | Science | 2024 | https://conductscience.org/library/papers/38207030 | PubMed |
| 18 | 16365420 | Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. | J Immunol | 2006 | https://conductscience.org/library/papers/16365420 | PubMed |
| 19 | 11309334 | Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11309334 | PubMed |
| 20 | 37139414 | The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy. | Acta Pharm Sin B | 2023 | https://conductscience.org/library/papers/37139414 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877588 | Innate immunity-stroma crosstalk in pancreatic cancer: overcoming spatial and metabolic barriers to immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42877588 | PubMed |
| 42724439 | Association between the systemic immune-inflammation index and overall survival in patients with leukemia: a multicenter cohort study. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724439 | PubMed |
| 42249048 | Human immunosuppressive neutrophils: recent answers to old and new questions. | EMBO J | 2026 | https://conductscience.org/library/papers/42249048 | PubMed |
| 42082461 | Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42082461 | PubMed |
| 41996628 | Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer-Associated Fibroblasts. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/41996628 | PubMed |
| 41980018 | Neonatal platelets differentiate monocytes to a myeloid-derived suppressor cell phenotype. | Blood | 2026 | https://conductscience.org/library/papers/41980018 | PubMed |
| 41946907 | Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/41946907 | PubMed |
| 41923521 | Ginkgolide B Alleviates Airway Inflammation in Hyperoxia Lung Injury. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/41923521 | PubMed |
| 41899581 | Overcoming MDSC-Mediated Immunosuppression in Hepatocellular Carcinoma: From Mechanisms to Novel Immunotherapeutic Approaches. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899581 | PubMed |
| 41686262 | CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer. | Cancer Immunol Res | 2026 | https://conductscience.org/library/papers/41686262 | PubMed |
| 41673656 | The unseen architects of metastasis: coagulation factors in pre-metastatic niche development. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41673656 | PubMed |
| 41451221 | Mechanistic roles of neutrophil heterogeneity in tumour pathogenesis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41451221 | PubMed |
| 41430564 | Microbial metabolite 5-formamidoimidazole-4-carboxamide ribotide targets METTL1 to inhibit m7G modification of BRCA1 mRNA to inhibit high-grade serous ovarian cancer. | Mol Med | 2025 | https://conductscience.org/library/papers/41430564 | PubMed |
| 41368640 | Mast cell metabolism in cancer: an underexplored frontier demanding more attention. | Front Immunol | 2025 | https://conductscience.org/library/papers/41368640 | PubMed |
| 40868150 | Lipid Metabolism Reprogramming in Cancer: Insights into Tumor Cells and Immune Cells Within the Tumor Microenvironment. | Biomedicines | 2025 | https://conductscience.org/library/papers/40868150 | PubMed |
| 40777001 | Immunotherapy enhances the risk of tumor oxidative stress and metastasis in lung cancer with radiation pneumonitis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40777001 | PubMed |
| 40487761 | Modulation of lipid metabolism by exercise: exploring its potential as a therapeutic target in cancer endocrinology. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40487761 | PubMed |
| 40214425 | Platelet-Activating Factor-Induced Inflammation in Obesity: A Two-Sided Coin of Protection and Risk. | Cells | 2025 | https://conductscience.org/library/papers/40214425 | PubMed |
| 40148954 | The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40148954 | PubMed |
| 39863828 | Arginine metabolism in myeloid cells in health and disease. | Semin Immunopathol | 2025 | https://conductscience.org/library/papers/39863828 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LPCAT2 | 54947 | PubTator's text mining | https://conductscience.org/library/genes/54947 | NCBI Gene |
| PCLAF | 9768 | PubTator's text mining | https://conductscience.org/library/genes/9768 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39178229
GET https://conductscience.org/api/papers/v1/39178229/references?page=2